TGFB additionally contributes to shaping the TME by promoting M2 macrophages and releasing interleukin-10 (IL-10), leading to an immunosuppressive cytokine milieu that contributes to a decreased immune response, ultimately hindering the effective action of CD8+ T-cells against tumor cells [35,36]. The gene discussed is IL10; the disease is neoplasm.